Toxoplasmosis in Cats: Neurological Symptoms, Cytology, Pregnancy Risks, and Veterinary Care

Introduction

Toxoplasmosis is a globally distributed protozoal disease caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii. Felidae serve as the definitive hosts, a critical distinction that governs the parasite's life cycle and epidemiology [1, 2]. In the domestic cat, infection can range from subclinical to severe multisystemic disease. Neurological involvement, while less common than enteric or systemic forms, carries a grave prognosis and demands sophisticated diagnostic and therapeutic interventions [3]. Conversely, primary reproductive complications in queens, particularly vertical transmission during gestation, represent a distinct pathological entity with significant implications for neonatal viability [4, 5]. This article provides a clinical and biophysical review of neurological toxoplasmosis, cytological diagnosis, pregnancy risks, and evidence based veterinary care in cats.

The parasite's life cycle within the feline definitive host involves both sexual replication in the intestinal epithelium, leading to oocyst shedding, and asexual replication (tachyzoites and bradyzoites) in extraintestinal tissues [2]. Oocyst shedding is most intense in naïve cats during primary infection, typically lasting one to three weeks [1]. Environmental contamination by sporulated oocysts is the primary route of transmission to intermediate hosts including birds, rodents, and humans [5]. Feline infection commonly occurs through predation on infected intermediate hosts or ingestion of oocysts from contaminated environments [1, 6].

Neurological Symptoms of Feline Toxoplasmosis

Pathogenesis of Neurological Disease

Neurological toxoplasmosis in cats arises from the hematogenous dissemination of tachyzoites following initial enteric infection. Tachyzoites display a tropism for neural tissue, actively crossing the blood-brain barrier through paracellular migration and infection of endothelial cells [7, 3]. Within the central nervous system (CNS), tachyzoites infect astrocytes, neurons, and microglial cells, forming foci of necrotizing inflammation. The host inflammatory response, characterized by lymphocytic and plasmacytic perivascular cuffing, microglial nodules, and intralesional accumulations of tachyzoites and bradyzoites, contributes to focal or diffuse encephalomyelitis [8, 3]. The immune status of the cat is a primary determinant of reactivation; cats with concurrent retroviral infections (e.g., feline leukemia virus) or those receiving immunosuppressive therapy are at elevated risk for recrudescence from tissue cysts [8].

Clinical Neurological Presentations

The clinical presentation of CNS toxoplasmosis is variable and dependent on the neuroanatomical localization of lesions. Common signs include asymmetric ataxia, paresis or paralysis (often pelvic limb), head tilt, circling, and seizures of either generalized or focal motor type [9, 3]. Cranial nerve deficits, including anisocoria, miosis, nystagmus, and facial nerve paralysis, are frequently observed [9, 3]. Upper motor neuron signs such as hyperreflexia and spasticity may be present with spinal cord involvement. Altered mentation, from obtundation to compulsive pacing, reflects forebrain involvement [7, 9]. Myoclonus, a series of involuntary rhythmic muscle contractions, has been described in both immunocompetent and immunosuppressed mammalian hosts and may be observed in feline toxoplasmic encephalitis [9, 3].

Brain Granuloma and Imaging Correlates

Focal granulomatous lesions are a characteristic histopathological finding in chronic CNS toxoplasmosis. These granulomas consist of a central core of necrotic debris and tachyzoites surrounded by epithelioid macrophages, lymphocytes, and glial cells [3]. Magnetic resonance imaging (MRI) of cats with cerebral toxoplasma granulomas reveals solitary or multiple contrast-enhancing mass lesions with perilesional edema, often localized within the cerebral cortex, basal ganglia, or thalamus [3]. These lesions can be structurally indistinguishable from neoplasia or fungal granulomas, underscoring the necessity of cytological or histopathological confirmation before initiating therapy.

Cytological Diagnosis of Neurological Toxoplasmosis

Cerebrospinal Fluid Analysis

Cytological examination of cerebrospinal fluid (CSF) is a cornerstone of antemortem diagnosis. CSF analysis typically reveals a mixed mononuclear pleocytosis, with elevated protein concentration reflecting blood-brain barrier disruption [3]. The presence of neutrophils may indicate acute necrotizing inflammation. Definitive cytological diagnosis requires the identification of extracellular or intracellular tachyzoites. Tachyzoites are crescent-shaped organisms measuring approximately 2 x 6 micrometers, with a basophilic cytoplasm and a distinct, eccentrically placed nucleus [3]. Their detection in CSF is specific but insensitive, as organisms are often sequestered within parenchymal lesions and not shed into the CSF compartment.

Tissue Aspiration Cytology

For parenchymal brain lesions identified on MRI, intraoperative or stereotactic fine-needle aspiration provides a higher diagnostic yield. Squash preparations of the aspirate stained with Romanowsky-type stains (e.g., Diff-Quik, Giemsa) allow visualization of tachyzoites within a background of necrotic debris and inflammatory cells [3]. Bradyzoites, the slowly replicating cyst form, may also be observed within intact tissue cysts. Differential cytological diagnoses for a contrast enhancing brain mass in a cat include lymphoma, meningioma, fungal granulomas (e.g., cryptococcoma), and bacterial abscess [3]. Immunocytochemical staining using anti-T. gondii antibodies can confirm the identity of the protozoal organisms on cytological specimens, enhancing diagnostic specificity.

Pregnancy Risks in the Queen

Pathophysiology of Transplacental Transmission

Transplacental (congenital) transmission of T. gondii in cats is a well-documented phenomenon but is epidemiologically less prevalent than acquired postnatal infection. Primary infection in a pregnant queen, or reactivation of a latent infection due to immunosuppression of gestation, can result in parasitemia [4, 5]. Tachyzoites cross the placental barrier and infect the fetal tissues. The stage of gestation at the time of infection governs the outcome. Early gestational infection often results in fetal resorption or abortion. Mid to late gestational infection may lead to stillbirth, mummification, or the birth of live kittens with multisystemic disease [4, 5].

Clinical Outcomes in Newborn Kittens

Kittens infected in utero may display a range of clinical signs at birth or within the first few weeks of life. Common manifestations include hepatomegaly, splenomegaly, pneumonitis, myocarditis, and icterus [5]. CNS signs in neonates include ataxia, cerebellar hypoplasia, hydrocephalus, and seizure activity [4, 10]. Ocular lesions such as chorioretinitis and anterior uveitis are also frequently reported [11, 6]. The classic triad of congenital toxoplasmosis in other species (chorioretinitis, hydrocephalus, and intracranial calcification) can be present in affected kittens [10].

Diagnostic Approach to Suspected Vertical Transmission

Diagnosis of congenital toxoplasmosis involves serological testing of the queen for immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies. A rising IgG titre or a positive IgM result indicates recent or active infection [12, 6]. Direct detection of the parasite in fetal tissues, placental samples, or neonatal blood can be achieved by polymerase chain reaction (PCR) amplification of T. gondii DNA. Histopathological examination of the placenta may reveal tachyzoites and necrotizing villitis [5].

Behavioural and Subclinical Manifestations

Beyond overt clinical disease, latent toxoplasmosis has been shown to induce measurable behavioural alterations in infected intermediate hosts. Infection with T. gondii has been associated with altered risk assessment and activity patterns in rodents, mediated by neuroinflammatory changes in the amygdala and other limbic structures [7, 13]. Cats, as the definitive host, do not serve as the primary experimental subject for such behavioural manipulation models. However, the presence of tissue cysts in the feline brain raises the possibility of similarly subtle neurological effects. Toxoplasma induced alterations in neurochemistry, particularly within the dopaminergic pathways, have been proposed as a mechanism for these behavioural modifications [7, 13].

Veterinary Care and Management

Diagnostic Workflow

The diagnostic approach to a cat with suspected toxoplasmosis integrates serology, PCR, cytology, and advanced imaging. Serum antibody detection using commercial ELISA kits is the primary screening tool. A positive IgM titre or a four-fold or greater rise in IgG titre over a two to three week period supports active infection [12, 6]. Detection of T. gondii DNA in blood, aqueous humor, or CSF by PCR provides a high specificity antemortem diagnosis. Imaging is indicated for cats with neurological signs; MRI is the preferred modality for detecting encephalic or spinal cord lesions [3]. The diagnostic decision tree for a neurologically affected cat is presented below.

graph TD
 A[Cat with Neurological Signs] --> B{CSF Analysis & Serum Toxoplasma Serology}
 B -->|Positive IgM / Rising IgG| C[Perform Brain MRI]
 B -->|Negative Serology| D[Consider Alternative Diagnoses]
 C --> E{"'Contrast-Enhancing Lesion(s') Identified"}
 E -->|Yes| F[CSF PCR for T. gondii]
 F --> G{Positive PCR}
 G -->|Yes| H[Probable Cerebral Toxoplasmosis]
 G -->|No| I[Consider Stereotactic Aspiration Biopsy]
 I --> J[Cytology & Immunocytochemistry]
 J -->|Tachyzoites Identified| H
 J -->|No Tachyzoites| D
 E -->|No| K[Diffuse Meningoencephalitis Pattern]
 K --> L[Empiric Anti-Toxoplasma Therapy]

Therapeutic Principles

The cornerstone of therapy for active toxoplasmosis in cats is the combination of a dihydrofolate reductase inhibitor (e.g., trimethoprim) with a sulfonamide (e.g., sulfadiazine). Alternative regimens include clindamycin, which acts by inhibiting protein synthesis at the 50S ribosomal subunit, or pyrimethamine combined with a sulfonamide [14, 9]. For neurological cases, clindamycin is often preferred due to its good penetration of the blood-brain barrier. Treatment duration is typically four to six weeks, but chronic cases may require extended therapy. Corticosteroids (e.g., prednisolone) are indicated for severe inflammatory or edematous reactions, particularly in cases of CNS or ocular disease, to mitigate secondary tissue damage. They must never be used without concurrent antiprotozoal therapy [14].

Oocyst Shedding and Environmental Control

For queens that have recently seroconverted or are known to be shedding oocysts, environmental management is critical. Oocysts shed in feces require one to five days to sporulate and become infective [2]. Daily removal of feces and disinfection of litter boxes with 70 degrees Celsius water or ammonia-based compounds inactivates oocysts. Pregnant women and immunocompromised individuals should not handle litter boxes or soil contaminated with cat feces [15, 11].

Prognosis

The prognosis for cats with neurological toxoplasmosis is guarded. Cats that receive early diagnosis and appropriate therapy may recover with residual deficits. Cats presenting with severe diffuse encephalitis or advanced granuloma formation have a poorer prognosis [3, 10]. Congenital infection in kittens carries a very high mortality rate, and survivors may suffer from permanent neurological or ocular damage [4, 5].

Conclusion

Feline toxoplasmosis is a complex disease with significant implications for both animal health and the environment. The neurological form, though challenging to diagnose, can be managed through a rigorous combination of cytological and molecular techniques. Pregnancy toxoplasmosis demands a distinct clinical vigilance, as vertical transmission can result in severe neonatal disease. The integration of advances in PCR based diagnostics and immunocytochemistry has improved the specificity of antemortem detection. Treatment with appropriate antiprotozoal agents, guided by the severity and location of infection, remains the foundation of clinical management.

References

[1] Ismail MT, Al-Kafri A. Prevalence of Toxoplasma gondii-like oocyst shedding in feral and owned cats in Damascus, Syria. J Vet Intern Med. 2023.

[2] Tomasina R, Francia ME. The Structural and Molecular Underpinnings of Gametogenesis in Toxoplasma gondii. Front Cell Infect Microbiol. 2020.

[3] Falzone C, Baroni M, De Lorenzi D et al. Toxoplasma gondii brain granuloma in a cat: diagnosis using cytology from an intraoperative sample and sequential magnetic resonance imaging. J Small Anim Pract. 2008.

[4] Hay J, Aitken PP, Arnott MA. The influence of congenital Toxoplasma infection on the spontaneous running activity of mice. Z Parasitenkd. 1985.

[5] Stagno S, Dykes AC, Amos CS et al. An outbreak of toxoplasmosis linked to cats. Pediatrics. 1980.

[6] Lopes FM, Gonçalves DD, Dos Reis CR et al. Presence of domesticated cats and visual impairment associated to Toxoplasma gondii serum positive children at an elementary school in Jataizinho, state of Paraná, Brazil. Rev Bras Parasitol Vet. 2008.

[7] Martynowicz J, Augusto L, Wek RC et al. Guanabenz Reverses a Key Behavioral Change Caused by Latent Toxoplasmosis in Mice by Reducing Neuroinflammation. mBio. 2019.

[8] Denk D, De Neck S, Khaliq S et al. Toxoplasmosis in Zoo Animals: A Retrospective Pathology Review of 126 Cases. Animals (Basel). 2022.

[9] Reyes AJ, Ramcharan K, Giddings SL et al. Myoclonic Jerks, Exposure to Many Cats, and Neurotoxoplasmosis in an Immunocompetent Male. Tremor Other Hyperkinet Mov (N Y). 2018.

[10] Kyllerman M, Strannegård O. Acquired toxoplasmosis and acute hemisyndrome in childhood. Arch Dis Child. 1979. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[11] Alvarado-Esquivel C, Liesenfeld O, Torres-Castorena A et al. Seroepidemiology of Toxoplasma gondii infection in patients with vision and hearing impairments, cancer, HIV, or undergoing hemodialysis in Durango, Mexico. J Parasitol. 2010.

[12] El-Beshbishi SN, El-Tantawy NL, Elzeky SM et al. Seroprevalence of Toxoplasma gondii infection in children with central nervous system disorders in Mansoura, Egypt: a case-control study. Trans R Soc Trop Med Hyg. 2018.

[13] Webster JP, Lamberton PH, Donnelly CA et al. Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour. Proc Biol Sci. 2006.

[14] Reyes AJ, Ramcharan K, Giddings SL et al. Myoclonic Jerks, Exposure to Many Cats, and Neurotoxoplasmosis in an Immunocompetent Male. Tremor Other Hyperkinet Mov (N Y). 2018.

[15] Flegr J, Lenochová P, Hodný Z et al. Fatal attraction phenomenon in humans: cat odour attractiveness increased for toxoplasma-infected men while decreased for infected women. PLoS Negl Trop Dis. 2011.